A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies — Stella
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
City of Hope, Duarte, California
Moffitt Cancer Center, Tampa, Florida
Emory University - Winship Cancer Institute, Atlanta, Georgia
Henry Ford Cancer Institute, Detroit, Michigan
Oregon Health and Science University, Portland, Oregon
TriStar Bone Marrow Transplant, Nashville, Tennessee
St. David's South Austin Medical Center, Austin, Texas
Methodist Hospital, Texas Transplant, San Antonio, Texas
University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah